(RBOT) Vicarious Surgical - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US92561V1098
RBOT: Surgical Robots, Robotic Systems
Vicarious Surgical Inc. (NYSE:RBOT) is a pioneer in the field of single-port surgical robotics, revolutionizing minimally invasive surgery with its cutting-edge technology. Founded in 2014 and headquartered in Waltham, Massachusetts, the company has developed the Vicarious Surgical System, which combines virtual reality and haptic feedback to provide surgeons with an immersive experience, allowing them to perform complex procedures with enhanced precision. This innovative approach reduces the need for multiple incisions, thereby minimizing patient recovery time and potential complications. The systems single-port design stands out in the market, offering a less invasive alternative to traditional surgical methods.
The companys commitment to advancing surgical robotics is evident through its focus on enhancing surgical outcomes and patient care. With a strong emphasis on research and development, Vicarious Surgical continues to push the boundaries of medical technology, aiming to make minimally invasive surgery more accessible and effective. For more information, visit their website at https://www.vicarioussurgical.com.
Additional Sources for RBOT Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
RBOT Stock Overview
Market Cap in USD | 49m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2020-09-04 |
RBOT Stock Ratings
Growth Rating | -68.6 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | 1.6 |
Analysts | 3.67/5 |
Fair Price Momentum | 4.68 USD |
Fair Price DCF | - |
RBOT Dividends
No Dividends PaidRBOT Growth Ratios
Growth Correlation 3m | -73.5% |
Growth Correlation 12m | 16.7% |
Growth Correlation 5y | -92.8% |
CAGR 5y | -52.67% |
CAGR/Max DD 5y | -0.53 |
Sharpe Ratio 12m | -0.88 |
Alpha | -21.55 |
Beta | 2.300 |
Volatility | 119.13% |
Current Volume | 11.4k |
Average Volume 20d | 12.8k |
As of May 09, 2025, the stock is trading at USD 8.84 with a total of 11,403 shares traded.
Over the past week, the price has changed by +11.19%, over one month by +74.02%, over three months by -29.28% and over the past year by -2.53%.
No, based on ValueRay Analyses, Vicarious Surgical (NYSE:RBOT) is currently (May 2025) a stock to sell. It has a ValueRay Growth Rating of -68.58 and therefor a clear technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of RBOT as of May 2025 is 4.68. This means that RBOT is currently overvalued and has a potential downside of -47.06%.
Vicarious Surgical has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold RBOT.
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, RBOT Vicarious Surgical will be worth about 5.6 in May 2026. The stock is currently trading at 8.84. This means that the stock has a potential downside of -36.54%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.8 | 21.6% |
Analysts Target Price | 11.8 | 32.9% |
ValueRay Target Price | 5.6 | -36.5% |